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Abstract  
Background and Aims  
We sought a robust behavioural test that evoked increased anxiety-like 
behaviour during the late diestrus phase of the estrous cycle (similar to 
the premenstrual period in women) and tested whether this could be 
prevented by acute low-dose fluoxetine. 
Methods 
Female Wistar rats in different stages of their cycle were exposed to 4 
different tests of anxiety-like behaviour.  
Results 
No estrous cycle differences were detected in fear potentiated startle or 
conditioned freezing to an aversive context. In a light switch-off test where 
rats move from one compartment of a shuttle-box to the other to turn off 
an aversive light, females displayed enhanced responding in late diestrus. 
During isolation restraint stress females in late diestrus emitted 3 times 
more 22 kHz ultrasound vocalizations (USV) than at other cycle stages.  
Using the USV test, short-term administration of low dose fluoxetine 
(1.75mg Kg-1, i.p.) designed to blunt the sharp fall in brain 
allopregnanolone concentration during late diestrus but without affecting 
5-HT systems, prevented the increase in isolation stress-evoked USVs. 
                  Conclusions 
The light switch-off and isolation restraint-induced USV tests evoke 
unconditioned adverse emotional responses that are ethologically 
relevant and sensitive to estrous cycle stage. The USV test fulfils many 
criteria required of a model for premenstrual syndrome in women. Using 
the USV test short term administration of fluoxetine to increase brain 
allopregnanolone concentration without affecting 5-HT systems, 
prevented the increased USV responding in late diestrus. Short-term low 
dose fluoxetine treatment may have potential to alleviate development of 
adverse premenstrual symptoms in women. 
 
 
Keywords: estrous cycle, fear, anxiety, startle, freezing, ultrasonic 
vocalisations; fluoxetine; female rat 
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Introduction 
In women, premenstrual syndrome (PMS) and its extreme form 
premenstrual dysphoric disorder (PMDD) is by far the most common 
female mental health disturbance, afflicting up to 80% of women of 
reproductive age (approximately 15-45 years old) (Tschudin et al, 2010).  
PMS is characterized by adverse psychological symptoms including 
anger, irritability, mood swings and anxiety that typically develop each 
month during the luteal phase of the menstrual cycle (Halbreich et al, 
2007). The condition is not well managed. Patients are advised on diet 
and lifestyle changes; and may be prescribed antidepressants – usually 
an SSRI (Imai et al, 2015; Ismaili et al 2016). Whilst these can be helpful 
in reducing symptoms, side effects are not uncommon, particularly after 
long term treatment (Majoribanks et al, 2013). Hormonal contraceptives 
that stabilise hormone levels are effective in some women, but symptoms 
persist in others, especially during the drug free period if intermittent 
dosing regimens are followed (Baker and O’Brien, 2012). In addition, the 
associated loss of fertility may be unwanted. 
During the late luteal phase, secretion of progesterone decreases rapidly. 
We found recently that women who develop PMS experienced a much 
sharper decline in progesterone towards the end of their late luteal phase, 
when symptoms are at their worst, compared to asymptomatic women in 
whom progesterone declined gradually (Lovick et al, 2017).  Measures to 
slow the rate of decline of progesterone during the luteal phase could 
therefore be a potential strategy to prevent the development of symptoms. 
 
In the female rat progesterone secretion declines rapidly during the late 
diestrus phase of the cycle (Butcher et al, 1975). Several studies have 
shown that a rapid decline in progesterone, and hence is neuroactive 
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metabolite allopregnanolone (ALLO) triggers upregulation of 
extrasynaptic GABAA receptor subunit expression, increased excitability 
of neural circuits involved in mediating anxiety-related behaviours and an 
increase in anxiety-like behaviour (Griffiths et al, 2005; Smith et al, 1998;    
Devall et al, 2009). Progesterone withdrawal has been adopted as a 
model of premenstrual dysphoria by several laboratories (e.g. Gallo and 
Smith, 1993; Li et al, 2012; Löfgren et al, 2009; Smith et al, 2006).  
Interestingly, the “withdrawal” effect of a sharp decline in progesterone 
was absent in rats in which progesterone concentration fell gradually 
(Doornbos et al, 2006). Based on these findings we hypothesized that 
measures to blunt the rapid fall in progesterone and hence ALLO during 
late diestrus should be able to prevent the behavioural disturbance.   
 
There have been few studies attempting to model premenstrual 
dysphorias in rats undergoing spontaneous cycles. However, increased 
aggression towards an unfamiliar conspecific has been reported during 
the two day diestrus phase (Ho et al, 2001).  Rats display hyperalgesia 
after being exposed to a short period of mild vibration stress in late 
diestrus but not when they were stressed at other stages of their cycle 
(Devall et al, 2009; 2015). Interestingly, the stress-induced hyperalgesia 
(SIH) in late diestrus was prevented by short term administration during 
early and late diestrus of fluoxetine (FLX), using a low dose (1.75mg Kg-
1).  FLX is classed a selective serotonin reuptake inhibitor (SSRI). 
However, at low concentration it has been shown to increase the brain 
concentration of allopregnanolone ALLO without affecting 5-HT systems 
(Devall et al 2015; Pinna et al, 2006; 2009). These novel findings 
suggested that short-term ALLO ‘replacement’’ had potential as a 
therapeutic strategy to prevent development of PMS in women.  
The SIH test is a relatively unwieldy tool since several days are needed 
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to complete the whole test protocol (Jørom; 1988; Devall et al, 2009).  We 
felt that the initial finding using this test should be validated in other animal 
models. We therefore sought to identify a higher throughput behavioural 
test in female rats that could detect estrous cycle differences in 
responsiveness to anxiogenic stress, and to determine whether blunting 
the rapid fall in ALLO concentration in late diestrus using sort term 
administration of low dose FLX, would prevent the development of 
symptoms.  
Initially we compared responding at different stages of the estrous cycle 
in four different tests of anxiety-related behaviours. We then chose the 
most promising test to investigate the effectiveness of short-term, low 
dose FLX in preventing the development of anxiogenic effects during the 
late diestrus phase. 
Tests used were: 
1) the widely used fear potentiated startle test (Davis, 1990)   
2) conditioned freezing to an aversive context (Curzon et al, 2009)  
3) a light switch-off test in which rats in a shuttle-box move to from one 
compartment to the other to turn off an aversive light (Saito and Brandão, 
2016)   
4) recordings of 22 kHz ultrasound vocalizations (USV) emitted during 
acute restraint stress (Schwarting and Wohr, 2012).  
   
Materials and Methods 
Ethical statement 
All experiments received formal approval (process 08.1.1547.53.3) from 
the Committee on Animal Research and Ethics (CEUA) of the University 
of São Paulo and were performed in compliance with the 
recommendations of the Brazilian Society for Neuroscience and Behavior, 
which are in accordance with the US National Institutes of Health Guide 
for the Care and Use of Laboratory Animals. The number of animals used 
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was the minimum required to ensure statistical reliability of the data; every 
effort was made to minimize the risk of any animal suffering. 
Animals 
A total of 239 Wistar rats, from the animal facility of the University of São 
Paulo at Ribeirão Preto were used. Females were at least 9 weeks old, in 
order to ensure that they were sexually mature and undergoing regular 
estrous cycles. Since the behavioural tests under investigation were 
developed and validated in male animals, we also included groups of age 
matched male rats to check that males responded in the expected way in 
our hands. Including a group of males would also show whether there 
were gross sex differences in responsiveness in the tests. The animals 
were housed in groups of four in plastic boxes 35 x 40 x 17cm maintained 
at an ambient temperature of 23oC on a 12h on 12h off light dark cycle 
with lights on at 7am. Free access to rat chow and water was available 
throughout. To minimize the possibility of extraneous confounding 
influences, all the animals were housed in the same room within our 
laboratory complex on delivery from the central animal facility. 
Experiments were carried out in adjacent rooms and only one 
experimenter (RMF) handled the animals.  We also set strict cytological 
criteria for determining estrous cycle stage (Brack et al, 2006).  
    Vaginal Smears 
All female rats went through a vaginal smearing procedure to determine 
the stage of their estrous cycle. A vaginal smear was taken daily in the 
morning (08.00-09.00h) and again following completion of each 
experimental test. An inoculation loop was sterilized in a flame, dipped in 
sterile water and then gently inserted into the vagina to gather cells, which 
were then smeared onto a glass slide. The smears were stained using a 
staining set (Panótico Rápido, Laborclin, Paraná, Brazil). Changes in the 
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cytological appearance of the smears were used to identify the cycle stage 
and to establish that the animals were cycling normally (Brack et al, 2006). 
The estrous cycle comprises four phases, each one with a different cell 
configuration: proestrus phase was characterized by an abundance of 
round nucleated epithelial cells; estrus phase by larger cornified 
squamous cells; in early diestrus an abundance of leucocytes, typically 
with multi-lobed nuclei was the main characteristic; late diestrus is 
characterized by fewer leucocytes whose nucleus has become diffuse 
with many cells appearing to be disintegrating. In previous studies we 
have found that this distinctive change in leucocyte morphology coincides 
with changes in functional brain status, which includes upregulation of 
certain GABAA receptor subunits, a change in neuronal excitability of the 
midbrain periaqueductal grey matter and altered responsiveness to 
anxiogenic drugs (Brack and Lovick, 2007; Devall et al, 2015; Lovick et al, 
2005; Soares-Rachetti et al, 2016). Only animals that had completed at 
least two regular cycles were used for behavioural experiments. Each rat 
was used for only one of the 4 behavioural tests. 
Fear-potentiated startle (FPS) 
Apparatus: The test cage was a wire-grid cage (16.5×7.5×7.5 cm) fixed to 
a response platform by four thumb screws. The floor consisted of six 3.0 
mm diameter stainless-steel bars spaced 1.5 cm apart. The cage and 
response platform were located inside a ventilated, sound-attenuating 
plywood chamber (64×60×40 cm). A loudspeaker located 10 cm behind 
the test cage delivered both the startle stimulus (100 dB, 50 ms burst of 
white noise) and continuous background noise (55 dB). The startle 
reaction of the rats generated pressure on the platform, and the analog 
signals were amplified, digitized and analyzed using Startle Reflex 
software (Med Associates, St. Albans, Vermont, USA). The startle 
  
 
8 
8 
reaction was recorded within a time window of 100ms after the onset of 
the startle stimulus. Calibration of the response platform was conducted 
before the experiments to ensure equivalent sensitivities across sessions.  
Baseline: On the first two days, the rats were placed in the test cage for a 
5 min habituation period and afterwards received a total of 30 startle 
stimuli with an inter-stimulus interval of 30 s. Each session lasted 20 min. 
The startle value of the second day (the mean startle amplitude of the 
session) was registered and considered as the baseline value for the 
animal.  
Training: 24 hours after establishing the baseline the rats were 
conditioned to associate the same experimental cage with an aversive 
environment. The rat was placed in the cage and 5 min later received 10 
footshocks (0.4 mA, 1 s) with a variable inter-trial interval of 60–180 s. 
Footshocks were delivered through the floor of the training cage by a 
constant-current generator built with a scrambler (Albarsch Instruments, 
Porto Alegre, Brazil) controlled by a microprocessor (Insight Equipments, 
Ribeirão Preto, Brazil). Each animal was removed 5 min after the last 
shock and returned to its home cage. The duration of each training 
session was approximately 25 min.  
Testing:  24 h after the training sessions the test sessions were conducted 
in the same cage as before, but without footshock presentation. After 5min 
of habituation, the rats received 30 startle stimuli (i.e. noise bursts) with a 
30s inter-stimulus interval. The value of the startle was compared with the 
baseline startle value. An increase startle amplitude was taken to reflect  
increase in anxiety level. All of the experimental steps were performed in 
the morning between 09.00h and 12.00h. 
Conditioned freezing 
Apparatus: Two distinct contexts, context A and context B, were used for 
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this experimental protocol.  Context A was used as a safe context. The 
chamber consisted on a transparent acrylic box (20 × 30 × 35 cm) with a 
flat stainless steel floor enclosed in a wooden sound-attenuating box 
containing a sound generator that produced a 1 kHz tone (72 dB; Insight 
Instruments, Ribeirão Preto, Brazil) and illuminated by a 40W white lamp. 
Context B was used for the conditioning sessions. The chamber 
(48×26×25 cm) had side and back walls made of black acrylic, and the 
ceiling and front door were made of transparent Plexiglas. The grid 
consisted of 36 stainless-steel rods spaced 1.5 cm apart through which 
footshocks could be delivered. The chamber also was enclosed in wooden 
sound-attenuating box with a loudspeaker and a sound generator to 
deliver a 1 kHz tone (72 dB; Insight Instruments, Ribeirão Preto, Brazil) 
and illuminated by a 15W red lamp.  
Habituation: The day before of the training and test session the animals 
were exposed to context A (safe) for 15 min. This period of habituation 
was important to decrease the novelty factor of the context on the test 
day.  
Training: Animals were placed in the context B, and after a 5 min 
habituation period, they were subjected to the training phase during which 
they received 10 footshocks (0.6 mA, 1 s) with an inter-trial interval that 
was varied randomly between 30 and 120 s. No explicit cue was 
presented between footshocks. Each animal was removed 5 min after the 
last shock and returned to its home cage. Training sessions lasted 
approximately 20 min.  
Testing: 6 hours after the training the animals were re-exposed first to 
context A (safe) and then the same animal was exposed to context B 
(aversive).  The time spent freezing during an 8 min period in each context 
was recorded by an observer. Freezing was operationally defined as the 
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total absence of movement of the animal, with the exception of 
movements related to respiration, for a period of at least 6s. An increase 
in time spent freezing was taken to represent an increase in fear. The 
testing session was performed in the afternoon between 13.00-15.00h.  
Both chambers were cleaned with 20% alcohol after each experiment. 
 
Light switch-off response (SOR) 
The experimental chamber consisted of a two-compartment shuttle box 
(30 cm ´ 25 cm ´ 25 cm; Insight Equipment, Ribeirão Preto, Brazil). The 
side and back walls of the chamber were made of black Plexiglas while 
the front and ceiling were made of transparent Plexiglas. The 
experimental chamber was equipped with a grid floor (15 x 2.0 mm 
diameter stainless-steel rods spaced 1.2 mm apart). The shuttle behavior 
of the animals was measured during the session by counting the number 
of times the floor tipped a fulcrum in the shuttle box as the rat moved from 
one side to the other. The chamber was illuminated by two 40W light 
bulbs, one in the center of each side of the rear wall of the chamber 12 
cm from the floor, which generated a light intensity of approximately 120 
lux measured at the floor level of the cage. The lights turned on and off 
silently. The light was switched off automatically when the rat moved to 
the opposite side of the box and remained lit in the absence of this 
response. The experimental chamber was located within a small, 
ventilated sound-attenuating box (50 cm ´ 40 cm ´ 35 cm). The behavior 
of the animals during the test sessions was recorded by a video camera 
(Everfocus, Duarte, California, USA) positioned in the lateral wall of the 
observation chamber, thereby allowing all behaviours to be monitored. 
The video signal was relayed via a closed circuit to a monitor located in 
an adjacent room.  
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Procedure. Each animal was placed inside the unlit shuttle box and 
allowed 5 min to habituate to the experimental context before the 
beginning of the session. The animal was then exposed to the light for 
20s. Whenever the rat passed from one side of the box to the other whilst 
the light was on (i.e. within 20 s), this response switched the light off 
(SOR).  Successive trials were separated by an interval of equal duration 
in which the light remained switched off. The presentation and sequencing 
of the light stimuli were controlled by the manufacturer’s software (Esquiva 
Ativa; Insight Equipments, Ribeirão Preto, Brazil), which also collected 
data on the number of shuttling responses during the light and dark events 
of the test in blocks of 10 trials (Reis et al. 2004). In the test conditions, 
each animal was submitted to only one session. The apparatus was 
cleaned with 20% alcohol between rats. The number of switch-off 
responses was taken as an inex of anxiety level. 
22 kHz ultrasound vocalizations (USVs) 
Procedure: The rat was placed in a restrainer (16 × 7 × 7 cm) made of 
steel rods spaced approximately 12 mm apart, which restricted the 
movement of the animal sufficiently to produce acute mild restraint stress. 
This restrainer was placed inside a larger, padded, echo-free (sound-
attenuated) and ventilated chest (60 × 40 × 45 cm) illuminated by a 28W 
red light bulb located at the top of the chamber. The test sessions 
consisted of placing the rat inside the restrainer for 10 min during which 
time ultrasonic vocalisations (USVs) were recorded. The animal was then 
removed from the restrainer and the whole apparatus cleaned thoroughly 
with 20% ethanol. 
For recording and analysis of USVs, an Electret ultrasound microphone 
(Emkay FG-3629; Avisoft Bioacoustics, Berlin, Germany) sensitive to 
frequencies of 1–100 kHz with a flat frequency response was positioned 
40 cm above the floor. It was connected via an Avisoft UltraSoundGate 
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116 USB audio device (Avisoft Bioacoustics) to a personal computer, 
where acoustic data were displayed in real time by Avisoft Recorder 
(version 2.7; Avisoft Bioacoustics) with a sampling rate of 214,285 Hz in 
16-bit format. For acoustical analysis, recordings were transferred to 
SASLab Pro (version 4.38; Avisoft Bioacoustics) and a fast Fourier 
transform was conducted (512 FFT- length, 100 % frame, Hamming 
window, and 75% time window overlap). Spectrograms were produced at 
a frequency resolution of 488 Hz and a time resolution of 0.512 ms. Calls 
were detected by an automatic threshold-based algorithm (threshold: –10 
dB; start/end threshold: −20 dB) and a hold-time mechanism (hold time: 
20ms) with a low cut-off frequency of 1 kHz. Call frequency and amplitude, 
derived from the average spectrum of each element, were determined 
automatically. Temporal parameters measured included total number of 
calls and call duration. An increase in either or both of these was taken to 
reflect increased anxiety level. 
 
Drug testing 
Fluoxetine hydrochloride (Sigma) was dissolved in saline. Two dosing 
regimens were tested. In the first one, drug (1.75 mg kg−1 i.p.) or saline 
vehicle was administered at 16:30–17:00 h on the evening of early 
diestrus. Testing was carried out in the early afternoon of the next day 
when the rats were in late diestrus. Fluoxetine (at least at higher doses 
than used here) raises brain ALLO concentration within an hour (Uzunov 
et al, 1996). Norfluoxetine, the major metabolite of FLX that is more potent 
than FLX itself at elevating ALLO concentration (Pinna et al; 2009), has a 
half-life in rat brain of around 8h following a single dose (Qu et al., 2009). 
Thus a single dose should be sufficient to blunt the sharp decline in ALLO 
in the brain as a consequence of the sharp decrease plasma 
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concentration of progesterone during early/late diestrus (Butcher et al, 
1974). 
The second dosing protocol was based on one we had found previously 
to be effective in preventing vibration stress-evoked hyperalgesia in late 
diestrus (Devall et al, 2015). Fluoxetine was given in the late afternoon of 
early diestrus with a second ‘top up’ injection the following morning 1 h 
prior to beginning behavioral testing. This dosing protocol was also 
followed for the control group, which received saline. 
 
Statistical analysis  
Data are presented as mean ± standard error of mean (SEM). Two-way 
repeated-measures ANOVA was carried out on the data using GraphPad 
Prism 7.0 (GraphPad Software, Inc., USA). The factor group refers to 
males and females in different stages of the estrous cycle and the factor 
condition refers to trial-type (noise alone or context + noise) in the FPS, 
safe and aversive context in the freezing test, blocks 1 to 4 in the light 
switch-off test and the recorded USV frequencies for the acute restraint 
stress, respectively. Post hoc differences between group means were 
evaluated using the Bonferroni or Tukey post hoc tests. P <0.05 was 
considered significant. 
 
RESULTS 
Fear-potentiated startle (FPS) 
Male and female rats at all stages of the estrous cycle displayed a similar 
baseline startle response, which increased in amplitude after being 
conditioned to the fearful environment. Figure 1A shows the startle 
amplitude in male (n=15) and female rats separated into groups according 
to the estrous cycle: P (n = 10), E (n =10), ED (n =10) and in LD (n = 10). 
Two-way repeated-measures ANOVA showed significant effects of trial 
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type (F1,50 = 8.71, p < 0.05) but no significant effect of groups (F4,50 = 
0.57, p > 0.05) and no group ´ trial type interaction (F4,50 = 0.15, p > 
0.05). The Bonferroni post hoc test revealed that compared to baseline 
trials, there was an overall enhancement of the startle response in male 
and females at all stages of their cycle in the trials conducted in the 
aversive context.  
 
Conditioned freezing to context 
Male and female rats at each stage of their cycle (n=8 for all groups) 
showed similar durations of freezing in the baseline condition and each 
group displayed an increase in freezing in the aversive context (Fig. 1B). 
Two-way repeated-measures ANOVA revealed a significant effect of trial 
type (F1,35 = 78.57, p < 0.05), but no significant effect of groups (F4,35 = 
2.12, p > 0.05) and no groups ´ trial type interaction (F4,35 = 0.58, p > 
0.05). The Bonferroni post hoc test revealed an overall enhancement of 
the freezing response in the aversive context trials compared with 
baseline trials in all groups tested.  
 
Light switch-off responses (SOR)  
Male rats and females in each stage of estrous cycle were submitted to 
the switch-off procedure (n= 9-10 per group). For analysis, the data was 
sub-divided by sex and cycle stage into 4 blocks of 10 consecutive trials 
(B1-B4).  Fig 1C shows the number of shuttles (SORs) made in response 
to 40 x 20s presentations of the light. At the beginning of the test males 
and females in all stages of their cycle made a similar number of shuttles 
from light to dark.  With the exception of rats in late diestrus, males and 
females showed a progressive decrease in the number of responses 
made in subsequent blocks of 10 trials. Two-way repeated-measures 
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ANOVA revealed a significant effect of blocks (F3,126 = 10.71, p < 0.05), 
groups (males and estrous cycle stages) (F4,42 = 3.05, p < 0.05) and 
groups ´ block interaction (F12,126 = 2.10, p < 0.05). The Bonferroni post 
hoc test revealed that, except for rats in late diestrus and to a lesser extent 
the proestrus phase, the number of SORs was reduced in the final block 
of the test (B4) compared with the beginning of the test (B1).  
.  
Ultrasound vocalizations (USVs) 
The number of USVs emitted during isolation restraint was measured in 
groups of male rats and females in each stage of the estrous cycle (Figure 
1D). In male rats the number of USVs in the 20-22KHz range was greater 
than at other frequencies (Fig 1D). In contrast, females as a group showed 
a very low level of USVs at all frequencies. However, when analysed with 
respect to estrous cycle stage, females in late diestrus were found to 
make a similar number of 20-22kHz USVs to male rats (Fig 1D). Two-way 
repeated-measures ANOVA applied to the number of USVs emitted 
during the 10min test period revealed significant main effects of USV 
frequency (F3,105 = 25.43, p <0.05), groups (F4,35 = 6.95, p <0.05) and 
interaction between groups and USV frequencies (F12,105 = 4.79, p < 
0.05). Tukey’s post hoc test showed a significant increase in USVs in 20-
22kHz range compared to 18-20kHz range only in males and females in 
late diestrus (p<0.05) (Fig 1D). There was no difference in 20-22kHz 
responding in females at other stages of the cycle. 
In terms of duration, there was a significant main effect with respect to 
USV frequencies (F3,105 = 8.77, p <0.05), groups (F4,35 = 3.3, p <0.05) 
and interaction between groups and USV frequencies (F12,105 = 2.8, p 
<0.05). Tukey’s post hoc test revealed that the duration of USVs in the 
20-22kHz range was significantly longer compared to 18-20kHz calls in 
males and females in LD but not the other cycle stages (p<0.05) (data not 
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shown).  
 
Effect of low dose fluoxetine 
We tested whether short term treatment with low dose FLX would prevent 
the increased sensitivity to isolation restraint stress seen in females in the 
late diestrus stage (n=7 per group). This series of experiments was carried 
out 24 months after completing the first study. In view of recent concerns 
about the reproducibility of data in behavioural studies and the need for 
ongoing test re-validation (Andrews et al, 2018), we considered it prudent 
to confirm the robustness of our initial findings in females before testing 
the effect of FLX. The second series of experiments was carried out by 
the same experimenter (RMF) in the same room and using the same 
equipment as in the initial study. In comparison to the first study carried 
out one year earlier, female rats in the second series of experiments 
emitted a greater number of USVs in all frequency ranges during isolation 
restraint stress.  We found that rats in late diestrus made significantly 
more calls in the 20-22kHz range than at other stages of their estrous 
cycle. They also appeared to make more calls in the 18-20kHz range 
although the difference did not reach statistical significance (Fig 2A).  
Two-way repeated ANOVA applied to the number of USVs emitted during 
the 10min test period revealed significant main effects of USV frequencies 
(F3,72 = 4.79, p < 0.05) and borderline effects of groups (F3,24 = 2.75, 
p=0.06), but no interaction between groups and USV frequencies (F9,72 
= 0.92, p > 0.05). Tukey’s post hoc test revealed that during restraint, 
females in late diestrus emitted a greater number of USVs in 20-22kHz 
rang than at other cycle stages although the difference reached statistical 
significance only for females in early diestrus. No significant effects were 
observed in relation to the durations of USV between USV frequency 
ranges (F3,72 = 1.61, p > 0.05), groups (F3,24 = 0.76, p > 0.05) or 
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interaction between groups and USV frequencies (F9,72 = 0.87, p > 0.05) 
(data not shown).  
 
A single dose of FLX (1.75mg Kg-1 ip)  administered in the afternoon of 
early diestrus before exposure to isolation restraint stress at around 
13.00h on the next day (rats now in their late diestrus phase), lead to a 
reduction in the number of 20-22kHz calls compared to saline-treated rats 
although the difference did not reach statistical significance (p=0.2; Fig 
2B).  On the other hand, when a second ‘top up’ dose of FLX was given 
in the morning of late diestrus before testing the rats later in the day, there 
was a significant reduction in calls made in the 20-22kHz range compared 
to saline-treated rats (n=9 or 10 per group). Two-way repeated ANOVA 
applied to the number of USVs emitted during the 10min test period 
revealed significant main effects of treatment (F2,26 = 5.54, p < 0.05), but 
no effects on USV frequencies (F3,78 = 0.74, p > 0.05) and interaction 
between treatment and USV frequencies (F6,78 = 0.68, p > 0.05). No 
significant effects were observed in relation to the durations of USV (F3,78 
= 0.16, p > 0.05), treatment (F2,26 = 2.36, p > 0.05) or interaction between 
treatment and USV frequencies (F6,78 = 0.49, p > 0.05) (data not shown). 
Tukey’s post hoc test revealed a significant reduction in number of 20-
22kHz USVs compared to saline-treated rats (p<0.05). Interestingly, after 
2 doses of FLX there was also a reduction in the number of calls made in 
the 18-20 and 22-24kHz range following two doses of FLX.  
 
Discussion 
In this study, we compared responses of male and female rats in 4 
behavioural tests of anxiety-related behavior. We were particularly 
interested to establish whether responsiveness of females was affected 
by estrous cycle stage. In tests using conditioned fear paradigms (fear 
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potentiated startle and conditioned fear to context), females as a group 
responded in the same way as males and we were unable to detect any 
difference in responsiveness at different stages of the estrous cycle. Our 
findings are in agreement with previous reports of similar experiments 
using Wistar and Lewis rats (Cossio et al 2016; Maeng et al., 2015; Pryce 
et al, 1999; Zhao et al, 2018).  On the other hand, they contrast with results 
of other studies using these tests in which males were reported to be more 
responsive than females (de Jongh et al, 2005; Gresack et al. 2009; 
Maren et al, 1994; Petterson et al, 1994).  This might reflect the rather 
different protocols as well as strains of rat used in the latter studies.  
 
                  In contrast to the tests evoking conditioned fear, clear estrous cycle linked 
differences were detected in performance in both the light switch-off and 
isolation restraint-induced ultrasound vocalisation tests. In the light 
switch-off test rats have the opportunity to extinguish an aversive light 
stimulus by moving to an unlit compartment of a shuttle box. As the 
experiment progresses, male rats make progressively fewer switch-off 
responses (SORs). This effect appears to reflect a reduction in the 
anxiogenic response to the light since it can be prevented by 
administering pro-aversive anxiogenic drugs (Saito and Brandão, 2016). 
In the present study males and female rats at all stages of their cycle 
responded similarly at the beginning of the test (Block 1). Females in late 
diestrus appeared to perceive the light to be aversive throughout the 
experiment suggesting they were more anxious than at other stages of 
their cycle. Rats at other stages of their cycle showed a progressive 
decrease in responding over successive blocks of trials although this 
effect was less pronounced in proestrus. During proestrus is estrogen 
levels are high and progesterone undergoes a spike (Butcher et al, 1974). 
Either of both of these factors could contribute to the behavioural profile 
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in proestrus.  
 
In line with these findings robust estrous cycle-linked differences were 
also displayed by females subjected to isolation restraint stress. Male rats 
exposed to stressful aversive behavioural situations emit 22kHz calls 
(Brudzynski, 2015; Portfors, 2007).  Males in our experiments emitted 
22kHz USVs during isolation restraint, suggesting they found the 
experience aversive whereas the females as a group emitted far fewer 
calls than males, suggesting that they were less stressed by the 
experience (Inagaki and Mori, 2015). However when estrous cycle stage 
was taken into account, emission of 22kHz calls  by females in late 
diestrus was some 3-fold higher than at other stages of the cycle, and 
reached the same level of responding as males. This suggests that the 
rats in late diestrus were much more stressed by isolation restraint in this 
phase than at other stages of their cycle.  
 
It is interesting to consider why female rats behaved so differently in four 
behavioural tests, all of which evoked a degree of fear and/or anxiety.  
One possibility relates to the level of anxiety induced by the different tests. 
The conditioned fear paradigms (conditioned fear to context and fear-
potentiated startle), both involve subjecting the animal to footshocks, 
which are overtly nociceptive. Reports of changes in pain threshold during 
the estrous cycle are equivocal (Devall et al, 2009; Gustafsson et al, 2011; 
Martinez-Gomez et al, 1994; Terner et al, 2005) and it is questionable 
whether subtle changes in threshold would be sufficient to influence the 
level of fear engendered by the reinforcing footshock stimulus during the 
conditioning stage. Even if there are estrous cycle linked differences in 
nociception, the level of fear evoked by the tests using footshock at all 
stages of the estrous cycle is likely to be much higher than evoked by the 
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light switch-off and restraint-induced ultrasonic vocalization tests. These 
are more naturalistic, ethologically relevant tests based on the innate fear 
of rodents for brightly-lit areas and the fear/anxiety engendered by being 
isolated and confined in a restricted space. It is important to note that our 
restraining cage does not impose the same level of distress on the animal 
as the complete immobilisation imposed in other studies, which is highly 
aversive (e.g. Costa et al., 2005; Gameiro et al., 2006).  We propose that 
if the level of anxiety induced by a procedure is relatively low, as in the 
light switch-off and ultrasound vocalisation tests used in the present study, 
or indeed the mild vibration stress used in previous studies (Devall et al, 
2015)  the behaviour of female rats can be influenced by the estrous cycle.  
On the other hand, high levels of fear engendered by footshock, may 
override any estrous cycle-linked influences which are revealed under 
more ethologically relevant testing situations. 
 
Progress in psychobiology is dependent on the development of 
appropriate robust animal models (Rodgers, 1997; Ennaceur and Chazot, 
2016; Stanford, 2017), never more so than in relation to development of 
sex-specific pharmacology for treatment of affective disorders in women. 
In women with PMS, the menstrual cycle influences principally emotion 
but has limited effect on cognitive function (Sundström-Poromaa, 2018). 
The adverse symptoms experienced in the late luteal (premenstrual) 
phase may be considered an inappropriate over-reaction to everyday 
psychological stressors that at other stages of their cycle do not trigger an 
adverse response. The isolation restraint stress test in female rats is 
ethologically relevant since it is based on the innate fear of rats to being 
confined and isolated and evokes an unconditioned emotional response 
(USVs). The test is sensitive to estrous cycle stage; it requires only one 
test session, which can be accomplished rapidly (10min) and data 
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collection is fully automated, thereby favouring relatively high throughput. 
The test appears to fulfil our criteria for a rodent model for developing 
potential new pharmacological strategies for treating premenstrual 
dysphorias in women.  
We were concerned by the differences in baseline level of responding in 
the two sets of experiments measuring USVs that were carried out a year 
apart. Reproducibility in behavioural testing in rodents is a major concern 
since both within- and between-lab differences are not uncommon 
(Andrews et al, 2018; Gulinello et al, 2018; Hogg 1996). As far as we can 
ascertain, nothing had changed in the experimental setting. Equipment, 
environment and experimenter and time of year were the same. However, 
our rats were obtained from the University’s central breeding facility and 
it is possible that some subtle change within that environment may have 
been responsible.  Another possibility is subtle changes in the 
environment within our local Departmental animal house where rats are 
housed for several weeks prior to and during the experimental period. 
Differences in the proportions and overall numbers of male and female 
rats housed there, or the number of visits to the room by staff from other 
research groups could have had an impact. Exposure of male rats to 
nociceptive stress (footshocks) lead to a long-lasting increase in numbers 
of 22kHz USVs tested one week later (Wöhr et al, 2005).  Although any 
stress experienced by our female rats is likely to have been far more 
subtle, these findings suggest that USVs may be a sensitive indicator of 
long term changes. However, we are reassured that despite differences 
in baseline, the phenotype in terms of estrous cycle and USVs was 
maintained.  In the second series of experiments, there was a tendency 
towards increased responsiveness in late diestrus in the 18-20kHz range 
so that responsiveness in late diestrus did not differ between these two 
groups, as they had done in the first study. It is worth noting that the so 
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called 22kHz calls considered to be indicators of anxiety/distress range 
from 18-32kHz (Sanchez, 2003; Schwarting and Wohr, 2012). It may be 
that if rats are more alert or anxious for some reason, as in our second 
study (see discussion page 20-21) their USV calls in response to isolation 
restraint generalised to include the 18-20kHz range.  Our experience 
highlights the necessity for replication (as done in this study) to check 
baseline data between studies.  
Notwithstanding these confounding factors, the results show clearly that 
the development of increased anxiety (enhanced 20-22kHz calls) in late 
diestrus could be prevented by short term treatment with low dose FLX. It 
is worth noting that FLX has not been reported to influence locomotor 
activity in female rats, even at doses higher than used in the present study 
(Fernandez-Guasti et al, 2017) and presumably would not interfere with 
rats’ ability to vocalise.  FLX increases brain concentration of ALLO by 
inhibiting its oxidation to 5α-dihydroprogesterone by a microsomal 
dehydrogenase (Fry et al, 2014). Based on the long half-life of 
norfluoxetine, the active metabolite of FLX (Qu et al 2009), we aimed to 
time dosing to offset the sharp fall in brain ALLO concentration that occurs 
during late diestrus so that brain concentration of the neurosteroid would 
decline more gradually (Devall et al, 2015; Pinna et al, 2009). In studies 
in which progesterone (and hence ALLO) concentrations have been 
manipulated artificially, the anxiogenic effect of rapid withdrawal from 
progesterone was ameliorated by withdrawing the steroid gradually 
(Doornbos et al, 2009). We have shown previously that increased anxiety-
like behaviour in late diestrus, when progesterone and hence 
allopregnanolone levels are falling steeply, corresponds with increased 
expression of GABAA receptor subunits and increased excitability of 
circuitry in parts of the brain associated with mediating fear and anxiety-
like behaviours (Griffiths and Lovick, 2005; Brack and Lovick, 2007; Devall 
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et al, 2015; Lovick et al., 2005).  We reasoned that short-term 
administration of low dose FLX in diestrus should, by raising brain 
concentration of ALLO via its steroid stimulating effect, offset these effects 
of the natural sharp fall in ALLO. Our present results support this 
hypothesis and confirm our earlier finding using a different behavioural 
test (Devall et al, 2015). Further experimentation is required to provide 
more direct evidence regarding the mechanism. 
 
The steroid stimulating effect of FLX is mediated by its metabolite 
norfluoxetine, which has a long half-life (Qu et al, 2009).  Based on this 
information we had reasoned that a single dose of FLX given approximately 
15h before behavioural testing might be sufficient to blunt the natural sharp 
decline in ALLO concentration. However, a single dose produced only 
modest (non-significant) reduction in isolation stress-evoked USVs in late 
diestrus. The steroid stimulating effect of FLX may therefore have been 
shorter lasting than expected, based on its reported half-life (Qu et al 2009). 
On the other hand, administration of FLX in the late afternoon of early 
diestrus, with a top up dose on the morning of late diestrus, completely 
prevented the development of the anxiogenic response in late diestrus. Our 
finding that a second dose of ALLO was required to prevent completely the 
increase in USVs during late diestrus does however, raise the question of 
whether this single dose on its own would have been effective.  ALLO has 
been reported to be anxiolytic at pharmacological doses (e.g. Brot et al, 
1997; Rogers and Johnson, 1998). However, at the physiological 
concentrations likely to be realized by the steroid-stimulating effect of FLX, it 
is anxiogenic (Andréen et al, 2009; Miczek et al, 2003, Gulinello and Smith, 
2003). It seems most unlikely therefore that the anxiolytic effect in late 
diestrus reflects an acute response to the second dose of FLX. Even so, 
experiments to address this point specifically need to be carried out. It is also 
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worth noting that in a previous study low dose FLX administered at other 
stages of the cycle had no effect on anxiety-like behaviour (Devall et al, 
2015), which would have been expected if its effects were due to a direct 
anxiogenic (or anxiolytic action). 
 
In summary, these initial findings show that low dose FLX below the 
threshold for activating serotonergic systems, is able to prevent the 
increased responsiveness to acute stress that characterises the late diestrus 
phase of the estrous cycle in female rats. Fluoxetine and other selective 
serotonin reuptake inhibitors have become the drugs of choice for treatment 
of premenstrual dysphorias in women, yet their mechanism of action is 
incompletely understood and perhaps surprisingly, both continuous dosing 
or intermittent dosing during the luteal phase appear to be equally effective 
(Majoribanks et al, 2013). The results of the present study suggest that at 
last part of their effectiveness may be due to their steroid-stimulating 
properties. Low doses of FLX taken during the late luteal phase as symptoms 
appear, should lead to a positive therapeutic outcome without the risk of 
adverse side effects of higher doses commonly used.    
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Fig.1. Responsiveness of male rats (M) and female rats at different stages 
of the estrous cycle in 4 different behavioural tests. Proestrus (P). Estrus 
(E). Early diestrus (ED). Late diestrus (LD). Results are expressed as 
mean ± SEM and subjected to two-way repeated measure ANOVA 
followed by Tukey’s post hoc test.  
A. Influence of the estrous cycle on the mean amplitude of startle 
response (arbitrary units) evoked by noise before and after exposure to 
aversive footshocks. * p < 0.05, compared with noise-alone trials in the 
same group (females: n = 10 per cycle stage; males: n=15).  
B. Duration of freezing elicited by re-exposure of rats to a safe context 
and to a context in which they had previously received aversive 
footshocks. * p < 0.05, compared with baseline trials in the same group; n 
= 8 for all groups.  
C. Number of crossings in the light (switch-off responses, SORs) made 
during 40 presentations of the light stimulus. Data subdivided into 4 blocks 
of 10 presentations (B1-B4). N=9-10 per group. * significantly different 
from B1 in the same group, p< 0.05. 
D. Number of vocalizations (USVs) emitted at ultrasound frequencies (18-
26 kHz) during 10 min of isolation restraint. * p < 0.05 in comparison to 
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the 18-20 kHz band for the same group used as a control. n = 8 in all 
groups. 
 
 
 
 
Fig 2. A. Number of USVs emitted during 10min isolation restraint stress 
in rats at different stages of the estrous cycle. N= 7 per group. * 
significantly different from early diestrus stage of the cycle in the 20-22 
kHz range (p<0.05, Tukey’s post hoc test). B. Effect of fluoxetine or saline 
on number of USVs emitted during isolation restraint stress in late 
diestrus. One dose: 1.75 mg kg-1 i.p. given in the afternoon of early 
diestrus; Two dose: a second dose given in the morning of late diestrus. 
* significantly different from saline-treated rats at the same frequency. 
 
